(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
3 days till quarter result
(amc 2024-05-08)
Expected move: +/- 10.46%
-3.75% $ 1.540
Live Chart Being Loaded With Signals
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs...
Stats | |
---|---|
Volumen de hoy | 355 378 |
Volumen promedio | 322 580 |
Capitalización de mercado | 77.78M |
EPS | $0 ( 2024-05-01 ) |
Próxima fecha de ganancias | ( $-0.440 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.680 |
ATR14 | $0.00800 (0.52%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-30 | Moore Stephen Michael | Sell | 4 523 | Common Stock |
2024-03-15 | Hall Christopher M | Buy | 400 000 | Stock Option (right to buy) |
2024-03-15 | Chen Richard | Buy | 175 000 | Stock Option (right to buy) |
2024-03-15 | Tachibana Aaron | Buy | 175 000 | Stock Option (right to buy) |
2024-03-15 | Moore Stephen Michael | Buy | 100 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
-62.68 |
Last 98 transactions |
Buy: 3 908 824 | Sell: 9 742 341 |
Volumen Correlación
Personalis Inc Correlación
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Personalis Inc Correlación - Moneda/Commodity
Personalis Inc Finanzas
Annual | 2023 |
Ingresos: | $73.48M |
Beneficio Bruto: | $18.21M (24.78 %) |
EPS: | $-2.25 |
FY | 2023 |
Ingresos: | $73.48M |
Beneficio Bruto: | $18.21M (24.78 %) |
EPS: | $-2.25 |
FY | 2022 |
Ingresos: | $65.05M |
Beneficio Bruto: | $13.35M (20.52 %) |
EPS: | $-2.48 |
FY | 2021 |
Ingresos: | $85.49M |
Beneficio Bruto: | $31.66M (37.03 %) |
EPS: | $-1.490 |
Financial Reports:
No articles found.
Personalis Inc
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities. The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves biopharmaceutical customers, universities, non-profits, and government entities. The company has partnership with Mayo Clinic; MapKure, LLC; SpringWorks Therapeutics, Inc.; and Moores Cancer Center. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico